Page last updated: 2024-08-25

lycorine and Invasiveness, Neoplasm

lycorine has been researched along with Invasiveness, Neoplasm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cong, X; He, Y; Hu, M; Liu, M; Peng, S; Qin, M; Xing, Y; Yi, Z1
He, P; Huang, A; Lan, L; Xing, Y; Yi, Z; Ying, X1

Other Studies

2 other study(ies) available for lycorine and Invasiveness, Neoplasm

ArticleYear
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
    Oncotarget, 2015, Jun-20, Volume: 6, Issue:17

    Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Phenanthridines; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Transplantation, Heterologous

2015
Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.
    Science China. Life sciences, 2017, Volume: 60, Issue:4

    Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Phenanthridines; Signal Transduction; src-Family Kinases; Xenograft Model Antitumor Assays

2017